James T. Miceli is 10% at IMMUNOSYN CORP (IMYN). They have made 7 open-market trades across 2 companies since 2007, most recently 2009-08-31.
CIK 0001385168
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $1.4B since 2007, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IMYN | 145,363,798 | — |
| PrivateUnlisted | 113,978,450 | — |
| Total | $0 |
Shares reported on the most recent Form 4, priced at the 2010-04-15 close. 2 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMYN | BUY | 2009-06-30 | 2010-04-15 | $0.07 | $41K | N/A | N/A | N/A |
| IMYN | SELL | 2007-11-01 | 2007-11-05 | $7.50 | $40K | N/A | N/A | N/A |
| IMYN | SELL | 2007-10-24 | 2007-11-05 | $5.00 | $40K | N/A | N/A | N/A |
| IMYN | SELL | 2007-10-24 | 2010-04-15 | $5.00 | $2.1M | N/A | N/A | N/A |
| PrivateIMMUNOSYN CORP | BUY | 2007-06-21 | 2007-09-04 | $1038.97 | $1.4B | N/A | N/A | N/A |
| IMYN | SELL | 2007-06-12 | 2007-10-25 | $5.02 | $4.0M | N/A | N/A | N/A |
| PrivateIMMUNOSYN CORP | SELL | 2007-04-26 | 2007-09-04 | $7038.78 | $1.9B | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.